Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT00685529

Public ClinicalTrials.gov record NCT00685529. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 24, 2026, 4:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Randomized, Multiple Dose, 3-Way Crossover Study of Arformoterol Tartrate Inhalation Solution and Foradil® (Racemic Formoterol) in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

Study identification

NCT ID: NCT00685529
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Enrollment: 24 participants

Conditions and interventions

Conditions

COPD

Interventions

Racemic formoterol Drug
Arformoterol tartrate inhalation solution Drug

Drug

Eligibility (public fields only)

Age range: 35 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 31, 2005
Primary completion: Sep 30, 2005
Completion: Sep 30, 2005
Last update posted: Feb 21, 2012

2005

United States locations

U.S. sites: 6
U.S. states: 5
U.S. cities: 6

Facility	City	State	ZIP	Site status
Not listed	Long Beach	California	—	—
Not listed	Fort Lauderdale	Florida	—	—
Not listed	Raleigh	North Carolina	—	—
Not listed	Simpsonville	South Carolina	—	—
Not listed	Spartanburg	South Carolina	—	—
Not listed	Spokane	Washington	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00685529, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 21, 2012 · Synced Jul 24, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00685529 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →